Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
breast cancer
Biotech
Roche reports phase 3 breast cancer victory for oral SERD
Roche has reported a phase 3 win for its oral SERD, bouncing back from an earlier setback to deliver data that could support filings for approval.
Nick Paul Taylor
Sep 22, 2025 7:25am
Pfizer, Arvinas lose interest in commercializing PROTAC drug
Sep 18, 2025 7:35am
BioNTech's ADC beats Roche’s Kadcyla in breast cancer phase 3
Sep 5, 2025 7:30am
Celcuity's breast cancer combo hits goals, teeing up FDA filing
Jul 28, 2025 6:00am
FDA clears Clairity's 5-year breast cancer risk prediction tool
Jun 5, 2025 1:00pm
Guardant360-guided breast cancer therapy swaps boost survival
Jun 3, 2025 10:00am